Promising ROd-cone DYstrophy Gene TherapY

Recruiting

Phase 1

Phase 2

Promising ROd-cone DYstrophy Gene TherapYPromising ROd-cone DYstrophy Gene TherapY

Sponsor:

SparingVision

Code:

NCT05748873

Conditions

Retinitis Pigmentosa

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

SPVN06

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-04-02. This information was provided to ClinicalTrials.gov by SparingVision on 2024-09-19.